Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3308862rdf:typepubmed:Citationlld:pubmed
pubmed-article:3308862lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3308862lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:3308862lifeskim:mentionsumls-concept:C0015980lld:lifeskim
pubmed-article:3308862lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:3308862lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:3308862pubmed:issue5lld:pubmed
pubmed-article:3308862pubmed:dateCreated1987-11-19lld:pubmed
pubmed-article:3308862pubmed:abstractTextHomogeneous E. coli-derived recombinant human interferon-beta (E. coli-rHuIFN-beta) was characterized in order to elucidate its physicochemical properties, as compared with those of fibroblast human interferon-beta (fibroblast HuIFN-beta). Purified E. coli-rHuIFN-beta and fibroblast HuIFN-beta exhibited a single band of Mr 19,000 and 23,000, respectively, on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The primary structure of E. coli-rHuIFN-beta was identical to the prediction from the cDNA sequence. Furthermore, both the circular dichroism (CD) spectra and the 1H nuclear magnetic resonance (NMR) spectra of E. coli-rHuIFN-beta and fibroblast HuIFN-beta at pH 6.8 were closely similar to each other. On the other hand, on reverse-phase high-performance liquid chromatography (HPLC) using a C18 column, the retention time of E. coli-rHuIFN-beta was longer than that of fibroblast HuIFN-beta. Moreover, although the isoelectric point of E. coli-rHuIFN-beta was pH 8.9, purified fibroblast HuIFN-beta exhibited multiple isoelectric points, probably due to heterogeneity of the carbohydrate moiety. These results indicate that the E. coli-rHuIFN-beta polypeptide folds similarly to fibroblast HuIFN-beta, and the carbohydrate moiety of natural HuIFN-beta has little influence on higher-order structure but does influence the hydrophobic and the electrostatic properties of the molecule.lld:pubmed
pubmed-article:3308862pubmed:languageenglld:pubmed
pubmed-article:3308862pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308862pubmed:citationSubsetIMlld:pubmed
pubmed-article:3308862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3308862pubmed:statusMEDLINElld:pubmed
pubmed-article:3308862pubmed:monthMaylld:pubmed
pubmed-article:3308862pubmed:issn0021-924Xlld:pubmed
pubmed-article:3308862pubmed:authorpubmed-author:HosoiKKlld:pubmed
pubmed-article:3308862pubmed:authorpubmed-author:ShimazuTTlld:pubmed
pubmed-article:3308862pubmed:authorpubmed-author:ShimizuHHlld:pubmed
pubmed-article:3308862pubmed:authorpubmed-author:KimuraSSlld:pubmed
pubmed-article:3308862pubmed:authorpubmed-author:YamazakiSSlld:pubmed
pubmed-article:3308862pubmed:authorpubmed-author:HanadaKKlld:pubmed
pubmed-article:3308862pubmed:authorpubmed-author:UtsumiJJlld:pubmed
pubmed-article:3308862pubmed:issnTypePrintlld:pubmed
pubmed-article:3308862pubmed:volume101lld:pubmed
pubmed-article:3308862pubmed:ownerNLMlld:pubmed
pubmed-article:3308862pubmed:authorsCompleteYlld:pubmed
pubmed-article:3308862pubmed:pagination1199-208lld:pubmed
pubmed-article:3308862pubmed:dateRevised2007-12-19lld:pubmed
pubmed-article:3308862pubmed:meshHeadingpubmed-meshheading:3308862-...lld:pubmed
pubmed-article:3308862pubmed:meshHeadingpubmed-meshheading:3308862-...lld:pubmed
pubmed-article:3308862pubmed:meshHeadingpubmed-meshheading:3308862-...lld:pubmed
pubmed-article:3308862pubmed:meshHeadingpubmed-meshheading:3308862-...lld:pubmed
pubmed-article:3308862pubmed:meshHeadingpubmed-meshheading:3308862-...lld:pubmed
pubmed-article:3308862pubmed:meshHeadingpubmed-meshheading:3308862-...lld:pubmed
pubmed-article:3308862pubmed:meshHeadingpubmed-meshheading:3308862-...lld:pubmed
pubmed-article:3308862pubmed:meshHeadingpubmed-meshheading:3308862-...lld:pubmed
pubmed-article:3308862pubmed:meshHeadingpubmed-meshheading:3308862-...lld:pubmed
pubmed-article:3308862pubmed:year1987lld:pubmed
pubmed-article:3308862pubmed:articleTitleCharacterization of E. coli-derived recombinant human interferon-beta as compared with fibroblast human interferon-beta.lld:pubmed
pubmed-article:3308862pubmed:affiliationBasic Research Laboratories, Toray Industries, Inc. Kanagawa.lld:pubmed
pubmed-article:3308862pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3308862pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3308862lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3308862lld:pubmed